Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • AU • USD
Creso Pharma Limited (COPHF) has a market capitalization of $131.72M and trades at $0.12. The 52-week range is 4.0E-4-9.466.
Key metrics include annual revenue of $18.92M.
The stock has a beta of -24.81, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
